SERUM INSTITUTE OF INDIA
Covovax, COVID-19 Vaccine Produced By Serum Institute of India Under Licence From Novavax, Gets WHO Approval For Emergency Use
Covavax: Serum Institute of India COVID-19 Vaccine for 3+ Kids by Mid-2022, Says Adar Poonawalla
UK-India Vaccine Certificate Recognition Row: Covishield Recognised But Indians To Quarantine On Arrival
COVID-19 Vaccine Update: Centre Plans To Procure 20 Crore Covishield, One Crore Zydus DNA Doses By End of September 2021
PM Modi, Mamata Banerjee, Adar Poonawalla Make It To Time Magazine's 100 Most Influential People List
PM Narendra Modi, Mamata Banerjee and Adar Poonawalla Among Time Magazine’s 100 Most Influential People of 2021
Cyrus Poonawalla Praises Narendra Modi Govt, Says ‘Difficulties in Getting Licences, Permissions for Vaccine Lessened’
COVID-19 Vaccine for Children: Expert Panel Recommends Nod to SII for Phase 2/3 Trials of Covovax on Children Aged 2-17
Sputnik V COVID-19 Vaccine to Be Produced at Serum Institute of India from September, Says RDIF
COVID-19 Vaccine Update: Govt Asks SII to Submit Trial Results of Adults For Novavax's Coronavirus Vaccine Covavax
Google Trends